Related Experiment Video
Updated: May 20, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
[Antiphospholipid syndrome and pregnancy].
1Semmelweis Egyetem, Általános Orvostudományi Kar I. Belgyógyászati Klinika Budapest Korányi S. u. 2/A 1083. gadok@freemail.hu
Antiphospholipid syndrome (APS) increases thrombotic risk in pregnancy. Timely thromboprophylaxis in pregnant women with APS is crucial for preventing adverse maternal and fetal outcomes and ensuring healthy births.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Immunology
Context:
- Antiphospholipid syndrome (APS) is a significant cause of severe thrombotic risk.
- Pregnancy naturally induces a hypercoagulable state, exacerbating thrombotic risk in women with APS.
- Thromboembolic events are a leading cause of maternal and fetal mortality.
Purpose:
- To highlight the critical role of thromboprophylaxis in managing antiphospholipid syndrome during pregnancy.
- To emphasize the need for centralized care and medication management for pregnant women with APS.
Summary:
- Antiphospholipid syndrome presents with thromboembolic events and antiphospholipid antibodies.
- Obstetric complications are common in APS, including recurrent miscarriage and fetal growth restriction.
- Effective thromboprophylaxis is essential for preventing complications and ensuring healthy pregnancies in women with APS.
Impact:
- Appropriate thromboprophylaxis can prevent thromboembolic complications in pregnant women with APS.
- Centralized management improves care for these high-risk pregnancies.
- Successful management leads to healthier outcomes for both mother and child.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Rh Blood Group
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
